Alembic Pharma wins USFDA nod for generic Dapagliflozin, secures 180-day exclusivity
Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
Paroxetine extended-release tablets are indicated for the treatment of major depressive disorder
The company, part of pharma powerhouse AbbVie, will showcase the findings—and the next evolution of its AA Signature framework—at AMWC 2026 in Monaco,
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
Nearly 12 million people are estimated to be living with glaucoma, making the country one of the worst affected globally
Subscribe To Our Newsletter & Stay Updated